Select high-purity recombinant and synthetic APIs manufactured via precision solid-phase automated synthesizers with end-to-end analytical traceability.
Sermorelin Acetate (GHRH 1-29 amide) represents a foundational growth-hormone-releasing factor in modern endocrinology, specialized anti-aging protocols, and regenerative medicine research.
Unlike exogenous rhGH, which suppresses endogenous pituitary axes via feedback inhibition, Sermorelin stimulates physiological pulsatile release of somatotropin. This biochemical advantage has driven an annual market expansion above 14.8% CAGR across North America, Europe, and the APAC longevity markets.
High racemization rates during the activation of the 29-amino-acid chain and downstream purification yield losses often result in volatile spot prices. Western CDMOs face compounding overheads, driving major international bio-distributors toward integrated high-volume synthesis hubs.
Commercial purchasers demand rigorous USP/EP compliance, with stringent limitations on deletion sequences (e.g., [des-Phe1]-sermorelin), residual trifluoroacetic acid (TFA), and bacterial endotoxin levels lower than 5 EU/mg for clinical and parenteral formulations.
Operating from our Heda Medicine Valley facility in Hangzhou, our automated multi-channel chemical peptide synthesis infrastructure eliminates the typical trade-off between speed, purity, and volume.
By synthesizing segment fragments via automated Solid-Phase Peptide Synthesis (SPPS) combined with Liquid-Phase fragment condensation, we minimize stereocenter epimerization at critical residues, boosting batch yields by 42% over legacy continuous solid-phase protocols.
China's domestic supply of premium Fmoc-protected amino acids, coupling agents (HBTU, HATU, PyBOP), and specialty resins gives Thinheal an unassailable 35-50% pricing advantage over Swiss and US synthesis facilities, passed directly into our transparent tier schedules.
Every delivered lot includes HPLC chromatograms, ESI-MS or MALDI-TOF mass spectrometry, residual counter-ion content (acetate conversion upon request), moisture determination via Karl Fischer titration, and complete sterility validation reports.
Direct contract manufacturer benchmark pricing for Research Grade (RUO), Clinical Trial batches, and Commercial Multi-Kilogram OEM runs.
| Order Tier / Application | Purity (RP-HPLC) | Counter-Ion | Lead Time | Estimated Cost / Gram (USD) | Audit Support |
|---|---|---|---|---|---|
| Pilot / Evaluation Tier (10g - 50g) | ≥ 98.0% | TFA or Acetate | 5 - 7 Business Days | $45.00 – $65.00 | Batch CoA, LC-MS, HPLC |
| Pre-Clinical / Formulation (100g - 500g) | ≥ 99.0% | Purified Acetate (<1% TFA) | 10 - 14 Business Days | $28.00 – $38.00 | Method Validation, Impurity Profiling |
| Commercial Supply (1kg - 5kg) | ≥ 99.5% | Pure Pharmaceutical Acetate | 3 - 4 Weeks | $14.00 – $22.00 | Full DMF File, Stability Studies |
| Industrial Multi-Kilogram Contract (>10kg) | Custom Specs | User Defined | Scheduled Release | Contract Negotiated | On-Site Regulatory Audit Support |
*Note: Final quotations may fluctuate based on specific salt-exchange requirements (e.g., sub-0.05% TFA limits), specialized packaging (lyophilized glass vials vs. bulk cryogenic containers), and regulatory dossier assembly.
How global therapeutic developers and biotech companies are integrating Sermorelin into multi-pathway therapeutic regimens.
Targeting age-related somatopause. Restoring insulin-like growth factor 1 (IGF-1) physiological ranges to support lean muscle maintenance and bone mineral density without excessive hyperinsulinemia.
Widespread R&D synergy pairing Sermorelin with GHRP analogues (such as Ipamorelin or GHRP-2) and tissue-repair peptides like BPC-157 for enhanced, multi-receptor cellular regeneration.
Transdermal and peptide nanocarrier encapsulation for topical cosmeceuticals aimed at cellular repair, epidermal thickness improvement, and fibroblast collagen activation.
Sublingual troches, nasal delivery sprays, and long-acting biodegradable microsphere depots designed to replace daily subcutaneous injections for chronic indications.
Navigating peptide synthesis hazards requires quantifiable quality criteria. Review our systematic six-checkpoint analytical criteria.
Require high-resolution RP-HPLC chromatograms showing base-line resolution between Sermorelin and [D-Ala]-epimers or [des-Arg]-truncated fractions.
Verify exact monoisotopic or average mass (MW: 3357.9 g/mol) through LC-HRMS, ruling out adduct ions or incomplete deprotection products.
Differentiate pure chromatographic purity from true peptide content. Thinheal delivers batches typically between 85% - 92% net content, with balance accounted by acetate salt and bounded water.
Strict headspace GC testing ensuring residual solvents (DMF, DCM, Acetonitrile, Piperidine) are well below ICH Q3C limits to eliminate cellular toxicity.
For sterile filling pipelines, bacterial endotoxin testing (LAL assay) validates lots conform to parenteral injectable constraints (<5.0 EU/mg).
Lyophilized peptides must be packaged in sealed Type I borosilicate vials under inert nitrogen atmosphere and transported via tracked sub-zero logistics.
Clear, technical answers to common queries regarding Sermorelin synthesis, scale-up, regulatory dossiers, and export terms.
Sermorelin is a synthetic 29-amino acid polypeptide representing the 1-29 fragment of endogenous human Growth Hormone-Releasing Hormone (GHRH). Its amino acid sequence is H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 with a molecular weight of 3357.88 Da.
Yes. While raw synthesis produces TFA salts, our downstream manufacturing includes automated preparative ion-exchange chromatography systems that convert Sermorelin to pure Acetate salt, achieving residual TFA levels well below 1.0% or custom limits under 0.1% for clinical trials.
We support dynamic scale-up starting from 10g pilot lots to 500g engineering runs, up to multi-kilogram commercial lots. Our total multi-ton chemical synthesis infrastructure guarantees supply continuity without batch variation.
Each batch ships with a detailed Certificate of Analysis (CoA) including RP-HPLC purity, ESI-MS or MALDI-TOF identity, amino acid analysis (AAA), residual water (Karl Fischer), residual solvents (GC), endotoxin levels, and bioburden testing data.
Lyophilized peptides are packaged under dry nitrogen in temperature-controlled VIP shippers with cold packs or dry ice. We maintain express clearance partnerships across North America, Europe, CIS, and the Middle East ensuring delivery in 3 to 5 business days.
Yes. In addition to standard Sermorelin Acetate, our custom peptide CDMO synthesizes modified variants, isotopic labels, fatty acid conjugations, and related GHRH analogues like Tesamorelin, CJC-1295 (DAC / No DAC), and selective secretagogues.
Browse our expanded commercial inventory of metabolic, tissue repair, neuroprotective, and cosmetic peptide APIs available for global dispatch.
Connect directly with our senior peptide synthesis chemists and regulatory desk. Inquire about customized batch targets, counter-ion exchanges, and tiered enterprise procurement agreements.
Thin